| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.3 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.3 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.032 | 0.3 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | -0.075 | 0.3 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | 0.04 | 0.3 |
| mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |